Literature DB >> 11793901

The Inventory of Personality Organization: psychometric properties, factorial composition, and criterion relations with affect, aggressive dyscontrol, psychosis proneness, and self-domains in a nonclinical sample.

M F Lenzenweger1, J F Clarkin, O F Kernberg, P A Foelsch.   

Abstract

This report describes 2 studies of the psychometric characteristics of the primary clinical scales of the Inventory of Personality Organization (IPO; O. F. Kernberg & J. F. Clarkin, 1995), which assess reality testing, primitive psychological defenses, and identity diffusion, in a nonclinical sample. The 3 IPO scales display adequate internal consistency and good test-retest reliability. Item-level confirmatory factor analysis supported a two-factor structure of the IPO consistent with O. F. Kernberg's (1984, 1996) model of borderline personality organization. Each of the 3 IPO scales was associated with increased negative affect, aggressive dyscontrol, and dysphoria as well as lower levels of positive affect consistent with Kernberg's model of borderline personality organization. The IPO Reality Testing scale is closely related to various measures of psychotic-like phenomena.

Entities:  

Mesh:

Year:  2001        PMID: 11793901

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  26 in total

1.  Emotion regulation and substance use frequency in women with substance dependence and borderline personality disorder receiving dialectical behavior therapy.

Authors:  Seth R Axelrod; Francheska Perepletchikova; Kevin Holtzman; Rajita Sinha
Journal:  Am J Drug Alcohol Abuse       Date:  2010-11-22       Impact factor: 3.829

2.  Evaluating the assessment of the ICD-11 personality disorder diagnostic system.

Authors:  Joshua R Oltmanns; Thomas A Widiger
Journal:  Psychol Assess       Date:  2019-01-10

3.  A bifactor model of personality organization in adolescence: the validity of a brief screening measure assessing severity and core domains of functioning.

Authors:  M Biberdzic; B F Grenyer; L Normandin; K Ensink; J F Clarkin
Journal:  BMC Psychiatry       Date:  2022-07-08       Impact factor: 4.144

4.  Borderline personality disorder and related constructs as risk factors for intimate partner violence perpetration.

Authors:  Michelle A Jackson; Lauren M Sippel; Natalie Mota; Diana Whalen; Julie A Schumacher
Journal:  Aggress Violent Behav       Date:  2015-05-02

5.  Development and Validation of a Self-Report Measure of Mentalizing: The Reflective Functioning Questionnaire.

Authors:  Peter Fonagy; Patrick Luyten; Alesia Moulton-Perkins; Ya-Wen Lee; Fiona Warren; Susan Howard; Rosanna Ghinai; Pasco Fearon; Benedicte Lowyck
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

6.  Toward a Better Understanding of the Relationship between Belief in the Paranormal and Statistical Bias: The Potential Role of Schizotypy.

Authors:  Neil Dagnall; Andrew Denovan; Kenneth Drinkwater; Andrew Parker; Peter Clough
Journal:  Front Psychol       Date:  2016-07-14

7.  Urban Legends and Paranormal Beliefs: The Role of Reality Testing and Schizotypy.

Authors:  Neil Dagnall; Andrew Denovan; Kenneth Drinkwater; Andrew Parker; Peter J Clough
Journal:  Front Psychol       Date:  2017-06-08

8.  Differences in Cognitive-Perceptual Factors Arising From Variations in Self-Professed Paranormal Ability.

Authors:  Kenneth Graham Drinkwater; Neil Dagnall; Andrew Denovan; Christopher Williams
Journal:  Front Psychol       Date:  2021-06-10

9.  The Inventory of Personality Organisation: its psychometric properties among student and clinical populations in Japan.

Authors:  Hiromi Igarashi; Hiroyoshi Kikuchi; Rikihachiro Kano; Hiroshi Mitoma; Masahiro Shono; Chieko Hasui; Toshinori Kitamura
Journal:  Ann Gen Psychiatry       Date:  2009-05-06       Impact factor: 3.455

10.  Reliability and validity of the German version of the Structured Interview of Personality Organization (STIPO).

Authors:  Stephan Doering; Markus Burgmer; Gereon Heuft; Dina Menke; Brigitta Bäumer; Margit Lübking; Marcus Feldmann; Susanne Hörz; Gudrun Schneider
Journal:  BMC Psychiatry       Date:  2013-08-13       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.